Literature DB >> 17911637

Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice.

Katsuhide Okunishi1, Makoto Dohi, Keishi Fujio, Kazuyuki Nakagome, Yasuhiko Tabata, Takahiro Okasora, Makoto Seki, Mihoko Shibuya, Mitsuru Imamura, Hiroaki Harada, Ryoichi Tanaka, Kazuhiko Yamamoto.   

Abstract

Hepatocyte growth factor (HGF) plays an important role in angiogenesis, cell proliferation, antifibrosis, and antiapoptosis. Moreover, recent studies have highlighted the immunosuppressive effect of HGF in animal models of allogenic heart transplantation and autoimmune myocarditis and in studies in vitro as well. We also reported that HGF significantly suppresses dendritic cell function, thus down-regulating Ag-induced Th1-type and Th2-type immune responses in allergic airway inflammation. However, the immunosuppressive effect of HGF in many other situations has not been fully clarified. In the present study, using a mouse model of collagen-induced arthritis (CIA) and experiments in vitro, we examined the effect of HGF on autoimmune arthritis and then elucidated the mechanisms of action of HGF. To achieve sufficient delivery of HGF, we used biodegradable gelatin hydrogels as a carrier. HGF suppressed Ag-induced T cell priming by regulating the functions of dendritic cells in the Ag-sensitization phase with down-regulation of IL-10. In contrast, under continuous Ag stimulation HGF induced IL-10-producing immunocytes both in vivo and in vitro. Moreover, HGF potently inhibited the development of CIA with enhancing the Th2-type immune response. We also confirmed that HGF significantly suppressed the production of IL-17 by immunocytes. These results indicate that HGF suppresses the development of CIA through different ways at different phases. They also suggest that HGF could be an attractive tool for treating patients with rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17911637     DOI: 10.4049/jimmunol.179.8.5504

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Role of hepatocyte growth factor in the immunomodulation potential of amniotic fluid stem cells.

Authors:  Tullia Maraldi; Francesca Beretti; Marianna Guida; Manuela Zavatti; Anto De Pol
Journal:  Stem Cells Transl Med       Date:  2015-04-14       Impact factor: 6.940

2.  Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells.

Authors:  Mahdia Benkhoucha; Marie-Laure Santiago-Raber; Gregory Schneiter; Michel Chofflon; Hiroshi Funakoshi; Toshikazu Nakamura; Patrice H Lalive
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-23       Impact factor: 11.205

3.  Anti-inflammatory activities of hepatocyte growth factor in post-ischemic heart failure.

Authors:  Shu-Ling Rong; Xiao-Lin Wang; Yi-Cheng Wang; Huan Wu; Xue-Dong Zhou; Ze-Kun Wang; Yu-Chuan Wang; Cun-Shui Xue; Bao Li; Dong-Lai Gao
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

Review 4.  The vasculature in rheumatoid arthritis: cause or consequence?

Authors:  Ewa M Paleolog
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

5.  Hepatocyte Growth Factor Suppresses Inflammation and Promotes Epithelium Repair in Corneal Injury.

Authors:  Masahiro Omoto; Kunal Suri; Afsaneh Amouzegar; Mingshun Li; Kishore R Katikireddy; Sharad K Mittal; Sunil K Chauhan
Journal:  Mol Ther       Date:  2017-05-11       Impact factor: 11.454

Review 6.  Immune mediators in the brain and peripheral tissues in autism spectrum disorder.

Authors:  Myka L Estes; A Kimberley McAllister
Journal:  Nat Rev Neurosci       Date:  2015-08       Impact factor: 34.870

Review 7.  Angiogenesis and its targeting in rheumatoid arthritis.

Authors:  Zoltán Szekanecz; Alisa E Koch
Journal:  Vascul Pharmacol       Date:  2009-02-13       Impact factor: 5.773

8.  Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies.

Authors:  Giuseppina Bonanno; Annabella Procoli; Andrea Mariotti; Maria Corallo; Alessandro Perillo; Silvio Danese; Raimondo De Cristofaro; Giovanni Scambia; Sergio Rutella
Journal:  J Transl Med       Date:  2010-11-09       Impact factor: 5.531

Review 9.  Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.

Authors:  V Finisguerra; H Prenen; M Mazzone
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

10.  Hepatocyte growth factor in dampening liver immune-mediated pathology in acute viral hepatitis without compromising antiviral activity.

Authors:  Renan Aguilar-Valenzuela; Eric D Carlsen; Yuejin Liang; Lynn Soong; Jiaren Sun
Journal:  J Gastroenterol Hepatol       Date:  2014-04       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.